SYRE vs CORT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

SYRE

55.3
AI Score
VS
SYRE Wins

CORT

36.3
AI Score

Investment Advisor Scores

SYRE

55score
Recommendation
BUY

CORT

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric SYRE CORT Winner
Forward P/E 0 19.305 Tie
PEG Ratio 0 0.813 Tie
Revenue Growth 0.0% 31.7% CORT
Earnings Growth -99.7% 24.1% CORT
Tradestie Score 55.3/100 36.3/100 SYRE
Profit Margin 0.0% 6.6% CORT
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY SYRE

Relative Price Performance (Last 90 Days)

SYRE 1M: +4.7% · 3M: -9.6% CORT 1M: -4.8% · 3M: +12.7%

Current Technical Phase

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.2 · Price: $92.33

CORT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 39.4 · Price: $107.50

Fundamentals Snapshot

Metric SYRE CORT
Market Cap — —
Forward P/E -26.3 24.4
Trailing P/E — 258.4
Revenue (TTM) — —
Revenue Growth 0.0% 0.3%
Gross Margin — 1.0%
Operating Margin 0.0% 0.2%
EPS -1.95 0.45
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.